Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Covington
Cerilliant
Deloitte
Mallinckrodt
Cantor Fitzgerald
Harvard Business School
Chubb

Generated: June 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050167

« Back to Dashboard

NDA 050167 describes POLYSPORIN, which is a drug marketed by Glaxosmithkline and Monarch Pharms and is included in two NDAs. Additional details are available on the POLYSPORIN profile page.

The generic ingredient in POLYSPORIN is bacitracin zinc; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the bacitracin zinc; polymyxin b sulfate profile page.
Summary for 050167
Tradename:POLYSPORIN
Applicant:Glaxosmithkline
Ingredient:bacitracin zinc; polymyxin b sulfate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:AEROSOL;TOPICALStrength10,000 UNITS/GM;2,000,000 UNITS/GM
Approval Date:Mar 1, 1985TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Medtronic
US Army
Harvard Business School
QuintilesIMS
Dow
AstraZeneca
Merck
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.